NCT05203172 2026-03-18The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical TrialsPfizerPhase 4 Recruiting46 enrolled
NCT02934568 2026-02-12Ribociclib (LEE011) Rollover Study for Continued AccessNovartisPhase 2 Active not recruiting22 enrolled
NCT01543698 2024-03-13A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid TumorsPfizerPhase 1/2 Completed189 enrolled 44 charts